Skip to main content
SpringerLink
Log in

Absence of severe neonatal ABO hemolytic disease at Intermountain Healthcare. Why?

  • Correspondence
  • Published:
Journal of Perinatology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Christensen RD, Baer VL, MacQueen BC, O’Brien EA, Ilstrup SJ. ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program. J Perinatol. 2018;38:517–25.

    Article  CAS  Google Scholar 

  2. Eggert LD, Wiedmeier SE, Wilson J, Christensen RD. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics. 2006;117:e855–62.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Women and Newborn’s Clinical Program, Intermountain Healthcare, Salt Lake City, UT, USA

    Vickie L. Baer & Robert D. Christensen

  2. Division of Neonatology, Department of Pediatrics, University of Utah Health, Salt Lake City, UT, USA

    Whitley Hulse, Timothy M. Bahr & Robert D. Christensen

  3. Transfusion Services and Clinical Pathology, Intermountain Healthcare, Murray, UT, USA

    Sarah J. Ilstrup

  4. Division of Hematology/Oncology, Department of Pediatrics, University of Utah Health, Salt Lake City, UT, USA

    Robert D. Christensen

Authors
  1. Vickie L. Baer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Whitley Hulse
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timothy M. Bahr
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sarah J. Ilstrup
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert D. Christensen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Whitley Hulse.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baer, V.L., Hulse, W., Bahr, T.M. et al. Absence of severe neonatal ABO hemolytic disease at Intermountain Healthcare. Why?. J Perinatol 40, 352–353 (2020). https://doi.org/10.1038/s41372-019-0553-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-019-0553-0

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation